S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Myomo Stock Forecast, Price & News

-0.02 (-1.19%)
(As of 07/1/2022 05:43 PM ET)
Today's Range
50-Day Range
52-Week Range
27,410 shs
Average Volume
106,107 shs
Market Capitalization
$11.42 million
P/E Ratio
Dividend Yield
Price Target

Myomo Stock Forecast (MarketRank)

Analyst Rating
3.00 Rating Score
713.3% Upside
$13.50 Price Target
Short Interest
0.29% of Float Sold Short
Dividend Strength
News Sentiment
Insider Trading
Proj. Earnings Growth
From ($1.31) to ($1.01) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.60 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive MYO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Myomo and its competitors with MarketBeat's FREE daily newsletter.

Myomo logo


Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

MYO Stock News Headlines

Myomo Reports First Quarter 2022 Financial Results
Myomo Q4 2021 Earnings Preview
See More Headlines

Industry, Sector and Symbol

Surgical appliances & supplies
Current Symbol
Year Founded

Company Calendar

Last Earnings
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
3 Analysts


Net Income
$-10.37 million
Pretax Margin


Sales & Book Value

Annual Sales
$13.86 million
Book Value
$2.25 per share


Free Float
Market Cap
$11.42 million
Not Optionable

Myomo Frequently Asked Questions

Should I buy or sell Myomo stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Myomo stock.
View analyst ratings for Myomo
or view top-rated stocks.

What is Myomo's stock price forecast for 2022?

3 Wall Street research analysts have issued twelve-month price targets for Myomo's stock. Their MYO stock forecasts range from $10.00 to $17.00. On average, they anticipate Myomo's share price to reach $13.50 in the next year. This suggests a possible upside of 713.3% from the stock's current price.
View analysts' price targets for Myomo
or view top-rated stocks among Wall Street analysts.

Are investors shorting Myomo?

Myomo saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 16,800 shares, an increase of 43.6% from the May 15th total of 11,700 shares. Based on an average trading volume of 45,700 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.3% of the shares of the stock are sold short.
View Myomo's Short Interest

How were Myomo's earnings last quarter?

Myomo, Inc. (NYSEAMERICAN:MYO) posted its quarterly earnings data on Wednesday, May, 11th. The company reported ($0.41) earnings per share for the quarter, topping the consensus estimate of ($0.54) by $0.13. Myomo had a negative trailing twelve-month return on equity of 74.05% and a negative net margin of 66.45%.
View Myomo's earnings history

Who are Myomo's key executives?

Myomo's management team includes the following people:
  • Mr. Paul R. Gudonis, Chairman, Pres & CEO (Age 67, Pay $459.18k)
  • Mr. David A. Henry, Chief Financial Officer (Age 61, Pay $369.01k)
  • Mr. Micah J. Mitchell, Chief Commercial Officer (Age 46, Pay $317.39k)
  • Dr. Harry Kovelman M.D., Chief Medical Officer (Age 63)

What other stocks do shareholders of Myomo own?

What is Myomo's stock symbol?

Myomo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MYO."

How do I buy shares of Myomo?

Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Myomo's stock price today?

One share of MYO stock can currently be purchased for approximately $1.66.

How much money does Myomo make?

Myomo (NYSEAMERICAN:MYO) has a market capitalization of $11.42 million and generates $13.86 million in revenue each year. The company earns $-10.37 million in net income (profit) each year or ($1.75) on an earnings per share basis.

How many employees does Myomo have?

Myomo employs 87 workers across the globe.

How can I contact Myomo?

Myomo's mailing address is One Broadway, 14Th Floor, CAMBRIDGE, MA 02142, United States. The official website for Myomo is myomo.com. The company can be reached via phone at (617) 996-9058 or via email at ir@myomo.com.

This page (NYSEAMERICAN:MYO) was last updated on 7/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.